Insider Transactions in Q4 2022 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2022
|
Atlas Venture Opportunity Fund Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
934,581
+50.0%
|
$9,345,810
$10.7 P/Share
|
|
Dec 12
2022
|
Jason P Rhodes |
BUY
Open market or private purchase
|
Indirect |
934,581
+50.0%
|
$9,345,810
$10.7 P/Share
|
|
Dec 12
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
680
-0.75%
|
$6,800
$10.87 P/Share
|
|
Dec 12
2022
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
3,322
-1.0%
|
$33,220
$10.87 P/Share
|
|
Dec 12
2022
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
628
-0.62%
|
$6,280
$10.87 P/Share
|
|
Dec 12
2022
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
751
-0.67%
|
$7,510
$10.87 P/Share
|
|
Dec 12
2022
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
472
-0.48%
|
$4,720
$10.87 P/Share
|
|
Dec 12
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
312
-0.55%
|
$3,120
$10.87 P/Share
|
|
Dec 09
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+30.58%
|
-
|
|
Dec 09
2022
|
Joshua T Brumm CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
144,000
+30.18%
|
-
|
|
Dec 09
2022
|
Wildon Farwell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+26.33%
|
-
|
|
Dec 09
2022
|
Susanna Gatti High Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+28.06%
|
-
|
|
Dec 09
2022
|
Jonathan Mc Neill Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+28.94%
|
-
|
|
Dec 09
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+35.43%
|
-
|
|
Oct 10
2022
|
Joshua T Brumm CEO & President |
SELL
Bona fide gift
|
Direct |
15,500
-3.83%
|
-
|
|
Oct 10
2022
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
195,800
-48.9%
|
$2,349,600
$12.46 P/Share
|
|
Oct 10
2022
|
Joshua T Brumm CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
195,800
+32.84%
|
$195,800
$1.03 P/Share
|
|
Oct 07
2022
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
14,200
-6.49%
|
$184,600
$13.37 P/Share
|
|
Oct 07
2022
|
Joshua T Brumm CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,200
+6.09%
|
$14,200
$1.03 P/Share
|